Trimebutine EP Impurity A

Development of a novel combination tablet containing trimebutine maleate and mosapride citrate for the treatment of functional dyspepsia
Kwan Hyung Cho, Young Keun Choi, Jun Heok Kang, Han-Gon Choi, Chul Soon Yong, Young-Joon Park
International Journal of Pharmaceutics Volume 400, Issues 1–2, 15 November 2010, Pages 145-152
 
RP-HPLC Determination of Related Impurities in Trimebutine Maleate and Assay of Components in Its Preparation
lin, zhi-hua; song, min
Chinese Journal of Pharmaceutical Analysis, Volume 21, Number 1, 1 January 2001, pp. 25-27(3)
 
A novel HPLC method for simultaneous determination of trimebutine, methylparaben and propylparaben in peroral medicines
Vladimir N. Zaitsev, Oleksandr A. Syrotchuk, and Iryna R. Didukh
Journal of Chemical and Pharmaceutical Research, 2015, 7(10):609-615
 
Different aspects in manipulating overlapped spectra used for the analysis of trimebutine maleate and structure elucidation of its degradation products
Hayam M. Lotfy, Eman M. Morgan, Yasmin Mohammed Fayez & M. Abdelkawy
Future Journal of Pharmaceutical Sciences volume 5, Article number: 7 (2019)

Trimebutine EP Impurity A is chemically 2-(dimethylamino)-2-phenylbutan-1-ol. Trimebutine EP Impurity A is supplied with detailed characterization data compliant with regulatory guideline. Trimebutine EP Impurity A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Trimebutine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.